Literature DB >> 21332386

Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds.

Teruo Murakami1, Ryoko Yumoto.   

Abstract

INTRODUCTION: Amine-containing basic compounds with pK(a) values of ≥ 7 for at least one functional group, or moderately strong amines, typically exhibit large distribution volumes with a marked interorgan variation. Understanding the tissue distribution mechanisms of various basic compounds is important for drug design. AREAS COVERED: This review focuses on the role of tissue phosphatidylserine (PS) binding in the characteristic tissue distribution of amine-containing basic compounds. The mechanisms underlying tissue distribution, including intercellular and intracellular distribution, and effects of pK(a) values and lipophilicity on the extent of tissue distribution of various basic compounds are clarified. EXPERT OPINION: The extent of tissue distribution of membrane-permeable moderately strong amines depends on tissue PS concentrations and binding affinities to PS. A linear relationship is observed between the extent of tissue distribution of each compound and tissue PS concentrations in various tissues. In contrast, very weakly basic compounds with pK(a) values of < 6.5 distribute to various tissues at almost comparable magnitudes, independent of tissue PS concentrations. Understanding the tissue distribution mechanisms and predicting Kp values for each tissue is essential in controlling pharmacological and/or toxic effects in pharmacotherapy with various amine-containing basic compounds, as well as in drug design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332386     DOI: 10.1517/17425255.2011.548805

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  8 in total

1.  Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.

Authors:  Zhuoya Wan; Jingjing Sun; Jieni Xu; Pearl Moharil; Jing Chen; Junchi Xu; Junjie Zhu; Jiang Li; Yixian Huang; Pengfei Xu; Xiaochao Ma; Wen Xie; Binfeng Lu; Song Li
Journal:  Acta Biomater       Date:  2019-03-28       Impact factor: 8.947

2.  In Vitro Mechanistic Study of the Distribution of Lascufloxacin into Epithelial Lining Fluid.

Authors:  Kouhei Ohya; Junichi Takano; Shigeru Manita
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis.

Authors:  Yichao Chen; Jingjing Sun; Yixian Huang; Yanhua Liu; Lei Liang; Da Yang; Binfeng Lu; Song Li
Journal:  Nanomedicine       Date:  2018-10-08       Impact factor: 5.307

4.  Interrogating the relationship between rat in vivo tissue distribution and drug property data for >200 structurally unrelated molecules.

Authors:  Andrew W Harrell; Caroline Sychterz; May Y Ho; Andrew Weber; Klara Valko; Kitaw Negash
Journal:  Pharmacol Res Perspect       Date:  2015-08-10

Review 5.  A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015.

Authors:  Zhihong O Brien; Mehran F Moghaddam
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

6.  A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (fu,cell).

Authors:  Andrea Treyer; Sandra Walday; Hinnerk Boriss; Pär Matsson; Per Artursson
Journal:  Pharm Res       Date:  2019-11-07       Impact factor: 4.200

7.  Study on the method to avoid infusion-site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells.

Authors:  Miho Yamasaki; Keisuke Oda; Takashi Ichinose; Marie Mizuguchi; Shoko Tominaga; Kei Omoda; Nobuhiro Mori; Yorinobu Maeda; Toshihiro Nishida; Teruo Murakami
Journal:  Oncol Lett       Date:  2022-09-16       Impact factor: 3.111

8.  Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor.

Authors:  Ehab El-Awaad; Robin Birus; Christelle Marminon; Zouhair Bouaziz; Laurens Ballentin; Dagmar Aichele; Marc Le Borgne; Joachim Jose
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.